iS Clinical launches the GeneXC Serum

04 Nov 2019

Skincare company iS Clinical has launched a new serum, the GeneXC. It is suitable for all skin types and aims to activate genes to enhance skin cells’ ability to respond to stress, renew cells, brighten the skin and improve the overall skin function, the company explains.

As well as this, iS Clinical has stated that the serum provides antioxidant protection, improvement in skin tone and elasticity, support in cellular regeneration and metabolism, and improve signs of ageing.

The key ingredients include, l-ascorbic acid (20% stabilised), trehalose, hydrolysed eruca sativa leaf, plankton extract, lecithin, terminalia ferdinandiana fruit extract, plankton extract, arginine ferulate, mixed fruit acid extracts and superoxide dismutase.

In a clinical study the skin was exposed to GeneXC Serum and gene expression was measured. Gene expression panels including 107 target genes and five endogenous control genes were analysed. Skin that was exposed to GeneXC showed increased antioxidant protection, improved hydration, enhanced skin barrier function, improved extracellular matrix integrity, enhanced cell renewal and repair and enhanced immune response.


Log-in to post a comment